{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:19Z","timestamp":1786119619745,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Immunization site pain is a common and unpleasant experience for both children and adults. It is a source of anxiety and distress and may ultimately result in nonadherence to vaccination schedules. There is limited information on how different brands of vaccines affect the intensity of immediate pain at the time of vaccine injection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Children in the United Kingdom (n = 178) were randomized to receive a booster dose of either the 10- or the 13-valent pneumococcal conjugate vaccine (PCV-10 or PCV-13). Immediate immunization site pain was assessed using validated pain assessment tools and crying time to investigate factors that may interfere with parental compliance to vaccination.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Pain measurements were available for n \u2265 74 and n \u2265 78 PCV-10 and PCV-13 recipients, respectively. PCV-13 recipients had significantly higher scores on the observer-rated modified behavioral pain scale than did those receiving PCV-10. No significant differences in the induction of pain between the 2 vaccines were found when a parent-rated pain assessment tool or crying time was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>PCV-10 administration was associated with slightly less acute pain compared with the injection of PCV-13, but the size of the difference was small and is of unknown clinical significance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000001894","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T15:53:27Z","timestamp":1515772407000},"page":"e103-e106","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Differences in Immunization Site Pain in Toddlers Vaccinated With Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine"],"prefix":"10.1097","volume":"37","author":[{"given":"Johannes","family":"Tr\u00fcck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sena","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merryn","family":"Voysey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260107","first-page":"1","article-title":"Report MW. Morbidity and mortality weekly report surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991 \u2013 2001 Centers for Disease Control and Prevention TM.","volume":"52","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.vaccine.2012.05.011","article-title":"Survey of the prevalence of immunization non-compliance due to needle fears in children and adults.","volume":"30","author":"Taddio","year":"2012","journal-title":"Vaccine"},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1016\/j.clinthera.2009.07.022","article-title":"Inadequate pain management during routine childhood immunizations: the nerve of it.","volume":"31","author":"Taddio","year":"2009","journal-title":"Clin Ther"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/j.vaccine.2012.03.085","article-title":"Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data.","volume":"30","author":"Gidudu","year":"2012","journal-title":"Vaccine"},{"key":"R5-20260107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.vaccine.2004.08.029","article-title":"Self-assessment of immediate post-vaccination pain after two different MMR vaccines administered as a second dose in 4- to 6-year-old children.","volume":"23","author":"Wood","year":"2004","journal-title":"Vaccine"},{"key":"R6-20260107","first-page":"e296","article-title":"Pain response to M-M-R vaccination in 4-6 year old children.","volume":"13","author":"Ipp","year":"2006","journal-title":"Can J Clin Pharmacol"},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1001\/archpedi.158.4.323","article-title":"Effect of choice of measles-mumps-rubella vaccine on immediate vaccination pain in infants.","volume":"158","author":"Ipp","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"5800","DOI":"10.1016\/j.vaccine.2006.05.004","article-title":"Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.","volume":"24","author":"Knutsson","year":"2006","journal-title":"Vaccine"},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1503\/cmaj.092048","article-title":"Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline (summary).","volume":"182","author":"Taddio","year":"2010","journal-title":"CMAJ"},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"e1184","DOI":"10.1542\/peds.2006-1107","article-title":"Pain reduction during pediatric immunizations: evidence-based review and recommendations.","volume":"119","author":"Schechter","year":"2007","journal-title":"Pediatrics"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/INF.0000000000001180","article-title":"The antibody response following a booster with either a 10- or 13-valent pneumococcal conjugate vaccine in toddlers primed with a 13-valent pneumococcal conjugate vaccine in early infancy.","volume":"35","author":"Tr\u00fcck","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R12-20260107","article-title":"Divergent memory B cell responses in a mixed infant pneumococcal conjugate vaccine schedule.","volume":"1","author":"Tr\u00fcck","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20260107","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1651-2227.2007.00021.x","article-title":"Oral glucose as an analgesic to reduce infant distress following immunization at the age of 3, 5 and 12 months.","volume":"96","author":"Thyr","year":"2007","journal-title":"Acta Paediatr"},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/adc.66.3.346","article-title":"Pain and measles, mumps, and rubella vaccination.","volume":"66","author":"Lyons","year":"1991","journal-title":"Arch Dis Child"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.vaccine.2010.12.051","article-title":"Evaluation of the reliability, validity and practicality of 3 measures of acute pain in infants undergoing immunization injections.","volume":"29","author":"Taddio","year":"2011","journal-title":"Vaccine"},{"key":"R16-20260107","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archpediatrics.2009.35","article-title":"Order of vaccine injection and infant pain response.","volume":"163","author":"Ipp","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R17-20260107","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/bmj.38906.704549.7C","article-title":"Effect of needle size on immunogenicity and reactogenicity of vaccines in infants: randomised controlled trial.","volume":"333","author":"Diggle","year":"2006","journal-title":"BMJ"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:34Z","timestamp":1786041934000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201804000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001894","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}